The metastatic cascade in prostate cancer
- PMID: 17150354
- DOI: 10.1016/j.suronc.2006.10.002
The metastatic cascade in prostate cancer
Abstract
Morbidity and mortality due to prostate cancer are mainly a result of prostate cancer metastases. After the initial neoplastic transformation of cells, the process of metastasis involves a series of sequential steps, which involve neoangiogenesis and lymphangiogenesis, loss of adhesion with migration away from the primary tumour and entry into the systemic vasculature or lymphatics. Metastatic growth in sites such as lymph nodes and bone marrow then involves the specific non-random homing of prostate cancer cells. An appreciation and understanding of this metastatic cascade in relation to prostate cancer is clinically important in order to stratify men with prostate cancer into prognostic groups. Moreover, it is crucial in the future development of therapies that can prevent metastases.
Similar articles
-
Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.Cancer Res. 2005 Nov 1;65(21):9789-98. doi: 10.1158/0008-5472.CAN-05-0901. Cancer Res. 2005. PMID: 16267000
-
The origin of prostate metastases: emerging insights.Cancer Metastasis Rev. 2015 Dec;34(4):765-73. doi: 10.1007/s10555-015-9597-6. Cancer Metastasis Rev. 2015. PMID: 26363603 Review.
-
Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis.Cancer Res. 2008 Oct 1;68(19):7828-37. doi: 10.1158/0008-5472.CAN-08-1488. Cancer Res. 2008. PMID: 18829538 Free PMC article.
-
CD151 is associated with prostate cancer cell invasion and lymphangiogenesis in vivo.Oncol Rep. 2014 Jan;31(1):241-7. doi: 10.3892/or.2013.2823. Epub 2013 Oct 29. Oncol Rep. 2014. PMID: 24174171
-
Microenvironmental regulation of metastasis.Nat Rev Cancer. 2009 Apr;9(4):239-52. doi: 10.1038/nrc2618. Epub 2008 Mar 12. Nat Rev Cancer. 2009. PMID: 19279573 Free PMC article. Review.
Cited by
-
Prostate cancer metastasis and soy isoflavones: a dogfight over a bone.EXCLI J. 2019 Feb 19;18:106-126. eCollection 2019. EXCLI J. 2019. PMID: 30956643 Free PMC article. Review.
-
Using circulating tumor cells to inform on prostate cancer biology and clinical utility.Crit Rev Clin Lab Sci. 2015;52(4):191-210. doi: 10.3109/10408363.2015.1023430. Epub 2015 Jun 16. Crit Rev Clin Lab Sci. 2015. PMID: 26079252 Free PMC article. Review.
-
miR186 suppresses prostate cancer progression by targeting Twist1.Oncotarget. 2016 May 31;7(22):33136-51. doi: 10.18632/oncotarget.8887. Oncotarget. 2016. PMID: 27121312 Free PMC article.
-
Stat3 promotes metastatic progression of prostate cancer.Am J Pathol. 2008 Jun;172(6):1717-28. doi: 10.2353/ajpath.2008.071054. Epub 2008 May 15. Am J Pathol. 2008. PMID: 18483213 Free PMC article.
-
Steps in prostate cancer progression that lead to bone metastasis.Int J Cancer. 2011 Jun 1;128(11):2545-61. doi: 10.1002/ijc.26024. Epub 2011 Mar 28. Int J Cancer. 2011. PMID: 21365645 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical